Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × Irinotecan × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Neoplasm Metastasis 6 Sarcoma, Ewing 5 Pancreatic Neoplasms 5 Rhabdomyosarcoma 4 Colonic Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Recurrence 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neuroblastoma 2 Neoplasms 2 Medulloblastoma 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Ependymoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1

Interventions

fludarabine 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Biopsy 2 treosulfan 1 talimogene laherparepvec 1 sodium-iodide symporter 1 relatlimab 1 entrectinib 1 cemiplimab 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Stem Cell Transplantation 1 Photons 1 Mycophenolic Acid 1 Ipilimumab 1 Immunoglobulin G 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Disulfides 1 Cyclosporins 1 Cyclosporine 1 CTLA-4 Antigen 1 Azacitidine 1 Abatacept 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡